Stockscreener 앱 받기
1.24
3.85%
-0.06
Entera Bio Ltd 주식(ENTX)의 최신 뉴스
Entera Bio Moves Toward Phase 3 With Oral Therapy That Could Transform Osteoporosis Treatment (NASDAQ: ENTX) - TradingView
Entera Bio (NASDAQ:ENTX) Stock Price Down 3%Here's What Happened - MarketBeat
Entera Bio Submits Streamlined Phase 3 Protocol to Initiate Registrational Program for EB613 in Postmenopausal Women with Osteoporosis - Bitget
Entera Bio submits streamlined Phase 3 protocol for oral osteoporosis drug - Investing.com
Entera Bio Submits Streamlined Phase 3 Plan for EB613 - TipRanks
Entera Bio submits streamlined Phase 3 protocol for EB613, seeks 12-month hip BMD primary endpoint - TradingView
Entera Bio (NASDAQ: ENTX) refines EB613 Phase 3 osteoporosis trial timeline - Stock Titan
Entera Bio submits streamlined phase 3 protocol to initiate registrational program for EB613 in postmenopausal women with osteoporosis - marketscreener.com
Entera Bio Submits Streamlined Phase 3 Protocol to Initiate - GlobeNewswire
Debt to equity ratio of Entera Bio Ltd. – HAM:5DT - TradingView
Aug Intraday: Is Entera Bio Ltd stock risky to hold nowMarket Volume Report & High Return Stock Watch Alerts - baoquankhu1.vn
ENTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
ENTX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Short Bowel Syndrome Market: High-Growth Opportunities for Investors to 2034DelveInsight - openPR.com
Entera Bio to Participate in the Leerink Partners 2026 Global Healthcare Conference - Yahoo Finance
Buyback Watch: Is Entera Bio Ltd stock risky to hold nowTrade Ideas & Low Volatility Stock Suggestions - baoquankhu1.vn
Entera Bio Heads Toward Phase 3 With EB613 in a 200 Million-Woma - GuruFocus
Entera Bio Heads Toward Phase 3 With EB613 in a 200 Million-Woman Osteoporosis Market (NASDAQ: ENTX) - TipRanks
Nasdaq Moves: Is BHRPRB impacted by rising ratesJuly 2025 Opening Moves & AI Forecast for Swing Trade Picks - baoquankhu1.vn
ENTXEntera Bio Ltd Latest Stock News & Market Updates - Stock Titan
Will Entera Bio Ltd. stock see insider buyingJuly 2025 Pullbacks & Accurate Buy Signal Alerts - mfd.ru
Entera Bio names former Pfizer executive Geno Germano as board chair - MSN
What pushed Entera Bio (ENTX) to rally nearly 16% after hours - MSN
What Pushed Entera Bio (ENTX) To Rally Nearly 16% After Hours - Benzinga
Entera Bio (ENTX) director buys 5,000 shares in open market trade - Stock Titan
Is Entera Bio Ltd. a good stock for dollar cost averaging2025 Support & Resistance & Verified Technical Trade Signals - mfd.ru
Will Entera Bio Ltd. stock outperform growth indexesEarnings Summary Report & Free High Accuracy Swing Entry Alerts - mfd.ru
Is Entera Bio Ltd. stock risky to hold nowWeekly Investment Summary & Growth Oriented Trading Recommendations - mfd.ru
Aug Momentum: Can Entera Bio Ltd deliver consistent dividendsEarnings Growth Summary & Low Volatility Stock Suggestions - baoquankhu1.vn
OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26 - GlobeNewswire Inc.
Why Entera Bio Ltd. stock could rally in 2025Chart Signals & Expert Approved Momentum Trade Ideas - mfd.ru
ENTX Rallies As Insiders Buy Company Shares — Retail Hopes For ‘Exciting Days’ Ahead - Asianet Newsable
Will Entera Bio Ltd. stock gain from government policiesJuly 2025 Sentiment & High Conviction Investment Ideas - mfd.ru
Insider Buying: Steven Rubin Acquires Shares of Entera Bio Ltd (ENTX) - GuruFocus
Sean Ellis Buys 18,000 Shares of Entera Bio (NASDAQ:ENTX) Stock - MarketBeat
Insider Buying: Entera Bio (NASDAQ:ENTX) Director Buys 10,000 Shares of Stock - MarketBeat
Entera Bio Shares Rise After Open Market Purchase By Board Members - Nasdaq
Entera Bio Ltd. Board Members and CEO Purchase Company Shares Amid Ongoing Development of Oral Therapies - Quiver Quantitative
Entera Bio insiders are buying more of their own shares on market - Stock Titan
Why Entera Bio Ltd. (5DT) stock is favored by hedge funds2025 Investor Takeaways & Accurate Trade Setup Notifications - mfd.ru
Entera Bio Names Geno Germano Independent Board Chairman - The Globe and Mail
Entera Bio appoints Geno Germano as board chairman By Investing.com - Investing.com South Africa
Entera Bio appoints former Pfizer executive Geno J. Germano as chairman of the board ahead of key milestones - marketscreener.com
Entera Bio Ltd: Geno J. Germano appointed as chairman of Entera Bio - marketscreener.com
Entera Bio Ltd. Announces Board Changes - marketscreener.com
Entera Bio Attracts Former Pfizer Group President as It Enters a New Phase (NASDAQ: ENTX) - GuruFocus
Entera Bio appoints Geno Germano as board chairman - Investing.com
Entera Bio Appoints Former Pfizer Executive Geno J. Germano as Chairman of the Board Ahead of Key Milestones - The Manila Times
Entera Bio Ltd. Appoints Geno J. Germano as New Chairman of the Board as Company Advances Oral Peptide Pipeline - Quiver Quantitative
Ex-Pfizer exec to lead Entera Bio board as 2026 oral PTH trials planned - Stock Titan
Opko Health (OPK) Expands Entera Partnership for Drug Co-Development - Finviz
Entera Bio Ltd. Files Initial Statement of Beneficial Ownership for Director Steven D. Rubin - Longbridge
OPKO and Entera expand collaboration to develop oral PTH treatment By Investing.com - Investing.com Nigeria
4.33%
자본화:
|
볼륨(24시간):